Spaltudaq

Spaltudaq Corporation, a privately-held biotechnology company, is focused on developing novel tumor-specific therapeutic human antibodies for the treatment of cancer and infectious disease. The company’s technology harnesses the power of the human immune system to identify tumor-specific or pathogen-specific monoclonal antibodies from human tissue samples.

Our website is currently under construction. Please contact us in the interim at info@spaltudaq.com